Longevity Wellness Pharmaceutical Market Growth, Key Players, SWOT, Revenue Analysis Analysis By Fact.MR
Rockville, Maryland, United States – September 22, 2026 – Longevity drug development is increasingly moving toward clinically defined diseases and measurable biological endpoints rather than broad claims about extending human life. Insilico Medicine's investigational drug rentosertib, currently in Phase 3 development for idiopathic pulmonary fibrosis, is being evaluated...
0 Comments 0 Shares 3 Views 0 Reviews